Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-247-0 | CAS number: 563-41-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- No GLP
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 005
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- Five animals per each group should be used. In the study, 3 and 4 animals were used per each group (Balb/C mice)
- GLP compliance:
- no
- Type of assay:
- mammalian germ cell cytogenetic assay
Test material
- Reference substance name:
- Semicarbazide hydrochloride
- EC Number:
- 209-247-0
- EC Name:
- Semicarbazide hydrochloride
- Cas Number:
- 563-41-7
- Molecular formula:
- CH5N3O.ClH
- IUPAC Name:
- semicarbazide hydrochloride
- Test material form:
- solid: crystalline
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: CBA and Balb/C
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Scanbur BK, Sollentuna, Sweden
- Age at study initiation: CBA - 6-8 weeks old, Balb/C - 6-7 weeks ols
- Weight at study initiation: CBA - 20-25 g, Balb/C - 15-25 g
- Assigned to test groups randomly: Yes,randomly divided into the different dose groups.
- Diet (e.g. ad libitum): Yes,standard diet , free access
- Water (e.g. ad libitum):Yes, tap water, free access
Administration / exposure
- Route of administration:
- intraperitoneal
- Details on exposure:
- Semicarbazide and positive control (Colchicine) were disolved in PBS to give solutions with different cocnentrations of the tested compound. All mice were given an acute single i.p. (10 ul/g b.w.) injection with test substance, negative control and positive control.
- Post exposure period:
- Blood samples were collected at 42 hours after injections.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- Experiment 1
- Dose / conc.:
- 40 mg/kg bw/day (nominal)
- Remarks:
- Experiment 1
- Dose / conc.:
- 80 mg/kg bw/day (nominal)
- Remarks:
- Experiment 1
- Dose / conc.:
- 120 mg/kg bw/day (nominal)
- Remarks:
- Experiment 1
- Dose / conc.:
- 80 mg/kg bw/day (nominal)
- Remarks:
- Experiment 2
- Dose / conc.:
- 120 mg/kg bw/day (nominal)
- Remarks:
- Experiment 2
- No. of animals per sex per dose:
- Experiment 1 - each dose group - Three of four animals.
Experiment 2 - 5 per group. - Control animals:
- yes, concurrent no treatment
- Positive control(s):
- Colchicine
- Route of administration: INTRAPERITONEAL
- Doses / concentrations: 1.0 mg/kg b.w
Examinations
- Tissues and cell types examined:
- Peripheral blood of mice.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Limited pre-study was carried out to set the maximum tolerated dose.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
Blood samples were collected, under light anaesthesia with Fluothane (Zeneca, Goteborg), from the orbital plexus of each animal, both CBA and Balb/C mice, at 42 h after injections. The choice of the sampling time is based on the knowledge that the time between the appearance of polychromatic erythrocytes (PCE) in bone marrow and peripheral blood is about 20 h. From each animal, about 50 ul of blood was drawn. Three parallel aliquots of 5ul of blood were layered for purification on a 65% Percoll (Pharmacia Biosystems, Uppsala, Sweden) gradient.
METHOD OF ANALYSIS:
Flow cytometry: Samples were analyzed on FACSVantage SE flow cytometer (BD Immunocytometry systems, Sunnyvale, CA) equipped with an argon ion laser (Enterprise II, Coherent, Santa Clara, CA) operating at both multiline UV and 488 nm. UV output power was 50 mW. Cells, one by one, pass the two beams. Here, the analysis rate was about 1000 cells per second. From each cell different electric signals are sent out, e.g. from forward scatter (FSC) and side scatter (SSC) information’s about structure and size are given. In this analysis a threshold was set in FSC to include all intact cells. Using CellQuest software, peak values for FSC, SSC, Thiazole orange fluorescence and Hoechst 33342 (HO342) fluorescence signals were collected. The FSC signals were acquired using a linear scale and the SSC, TO and HO342 signals were acquired using a log scale.
From each sample between 20 000 and 100 000 events (cells) were collected. CellQuest software (BD) was used for data acquisition and analysis.
For the calculation of MPCE frequencies, dot plots of FSC versus SSC, and DNA content (HO342), indicating the presence of MN, versus RNA (TO) content, indicating the age of the erythrocytes were displayed for each analysed sample.
The cells in the pellet were fixed in a solution of glutaraldehyde. The fixed cells were then stored during 2–5 days at 4 ◦C and the following staining was made in a buffer prepared by adding the fluorescent dyes Hoechst 33342 (HO 342) (Sigma–Aldrich, Sweden) and Thiazole orange (TO) (Molecular probes, Eugene, OR, USA) to PBS. HO
342 is a DNA dye and TO is a RNA dye. - Statistics:
- The two-tailed, Student t-test was used for a statistical evaluation of the results.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 200 (four mice), 80 (three mice), and 50 mg/kg b.w. (three mice).
- Clinical signs of toxicity in test animals: The highest dose (200 mg/kg b.w.) of semicarbazide hydrochloride - all four tested mice died within 1 hour. At the doses of 80 mg/kg or 50 mg/kg b.w. - no sign of adverse effect was noticed.
On the bases of these results and LD50 from another study, the selected dose in the micronucleus test were 40,80 and 120 mg/kg bw.
Any other information on results incl. tables
Results from the micronucleus assay with semicarbazide in Experiment 1
Strain |
Animal code |
Dose Mg/kg bw |
%PCE |
S.D. |
PCE |
Number of MPCE |
fMPCE per mille |
S.D. |
Balb/C |
101 |
0 |
20 |
|
204 589 |
400 |
1.95 |
|
Balb/C |
102 |
0 |
2.3 |
|
220 700 |
345 |
1.56 |
|
Balb/C |
103 |
0 |
3.6 |
|
224 589 |
434 |
1.93 |
|
Balb/C |
104 |
0 |
2.3 |
|
221 667 |
392 |
1.77 |
|
Balb/C |
101-104 |
0 |
2.5 |
0.72 |
871 545 |
1571 |
1.8 |
0.18 |
Balb/C |
105 |
40 |
1.5 |
|
96 745 |
166 |
1.71 |
|
Balb/C |
106 |
40 |
1.7 |
|
209 819 |
355 |
1.69 |
|
Balb/C |
107 |
40 |
2.3 |
|
216 084 |
399 |
1.84 |
|
Balb/C |
105-107 |
40 |
1.8 |
0.40 |
522 648 |
920 |
1.76 |
0.08 |
Balb/C |
112 |
80 |
2.3 |
|
220 071 |
380 |
1.72 |
|
Balb/C |
113 |
80 |
1.7 |
|
201 970 |
381 |
1.88 |
|
Balb/C |
114 |
80 |
2.1 |
|
202 810 |
434 |
2.14 |
|
Balb/C |
112-114 |
180 |
2.1 |
0.33 |
624 851 |
1195 |
1.91 |
0.34 |
Balb/C |
115 |
120 |
2.2 |
|
222 684 |
413 |
1.85 |
|
Balb/C |
116 |
120 |
2.2 |
|
208 059 |
422 |
2.02 |
|
Balb/C |
117 |
120 |
2.4 |
|
226 696 |
502 |
2.21 |
|
Balb/C |
118 |
120 |
2.1 |
|
216 086 |
435 |
2.01 |
|
Balb/C |
115-118 |
120 |
2.2 |
0.17 |
873 525 |
1772 |
2.02 |
0.12 |
Balb/C |
118 |
Colch. |
0.8 |
|
30 217 |
216 |
7.10 |
|
Balb/C |
109 |
Colch. |
1.0 |
|
58 302 |
376 |
6.41 |
|
Balb/C |
110 |
Colch. |
0.9 |
|
44 331 |
401 |
8.96 |
|
Balb/C |
108-110 |
Colch. |
0.8* |
0.14 |
132 850 |
993 |
7.4* |
1.32 |
∗ p < 0.001 (Student t-test, two-tailed).
Results from the micronucleus assay with semicarbazide in Experiment 2
Strain |
Animal code |
Dose Mg/kg bw |
%PCE |
S.D. |
PCE |
Number of MPCE |
fMPCE per mille |
S.D. |
Number of MPCE (II) |
fMPCE (II) per mille |
S.D. |
CBA |
1 |
0 |
2.3 |
|
65 645 |
68 |
1.03 |
|
38 |
0.58 |
|
CBA |
2 |
0 |
1.6 |
|
170 903 |
237 |
1.38 |
|
112 |
0.65 |
|
CBA |
3 |
0 |
2.2 |
|
201 091 |
201 |
1.00 |
|
96 |
0.48 |
|
CBA |
4 |
0 |
2.4 |
|
213 483 |
217 |
1.02 |
|
103 |
0.48 |
|
CBA |
5 |
0 |
2.0 |
|
191 284 |
166 |
0.87 |
|
76 |
0.40 |
|
CBA |
1-5 |
0 |
2.0 |
0.31 |
842 406 |
889 |
1.05 |
0.9 |
425 |
0.50 |
0.010 |
CBA |
6 |
80 |
1.7 |
|
176 295 |
168 |
0.95 |
|
88 |
0.50 |
|
CBA |
7 |
80 |
2.2 |
|
230 744 |
222 |
0.96 |
|
107 |
0.46 |
|
CBA |
8 |
80 |
2.1 |
|
245 383 |
242 |
0.99 |
|
119 |
0.48 |
|
CBA |
9 |
80 |
1.9 |
|
224 674 |
197 |
0.88 |
|
87 |
0.39 |
|
CBA |
10 |
80 |
1.8 |
|
193 270 |
165 |
0.85 |
|
79 |
0.41 |
|
CBA |
6-10 |
80 |
1.9 |
0.21 |
1 070 366 |
994 |
0.93 |
0.06 |
480 |
0.45 |
0.05 |
CBA |
11 |
120 |
2.0 |
|
219 505 |
199 |
0.91 |
|
98 |
0.45 |
|
CBA |
12 |
120 |
1.6 |
|
206 114 |
171 |
0.83 |
|
77 |
0.37 |
|
CBA |
13 |
120 |
2.0 |
|
204 669 |
178 |
0.87 |
|
88 |
0.45 |
|
CBA |
14 |
120 |
1.9 |
|
196 744 |
181 |
0.92 |
|
92 |
0.47 |
|
CBA |
15 |
120 |
2.3 |
|
237 726 |
186 |
0.78 |
|
78 |
0.33 |
|
CBA |
11-15 |
120 |
2.0 |
0.23 |
1 064 758 |
915 |
0.86 |
0.06 |
433 |
0.41 |
0.06 |
CBA |
16 |
Colch. |
0.46 |
|
22 381 |
88 |
3.92 |
|
62 |
2.76 |
|
CBA |
17 |
Colch. |
0.74 |
|
34 740 |
137 |
3.93 |
|
98 |
2.81 |
|
CBA |
18 |
Colch. |
0.55 |
|
29 939 |
112 |
3.73 |
|
81 |
2.70 |
|
CBA |
1-18 |
Colch. |
0.6* |
0.14 |
87 060 |
337 |
3.9* |
0.11 |
241 |
7.86* |
0.06 |
∗ p < 0.001 (Student t-test, two-tailed).
Applicant's summary and conclusion
- Conclusions:
- The test substance does not show any visual signs of distress (fur condition, wakefulness, etc) nor adverse effects in two different mouse strains.
- Executive summary:
According the present study, test substance was tested for genotoxicity in the flow cytometry-based micronucleus assay in vivo. Two strains of male mice were used (CBA and Balb/C). They were injected intraperitonealy with test substance. Before the main test, range finding study was performed to set the maximum tolerated dose. Positive (Colchicine) and negative control (PBS) groups were used too. Test substance and positive control (Colchicine) were disolved in PBS to give solutions with different cocnentrations of the tested compound. All mice were given an acute single i.p. (10 ul/g b.w.) injection with test substance, negative control and positive control.The mice were randomly divided into groups. Two experiments were carried out. Experiment 1 with doses 0, 40,80 and 120 mg/kg/bw and experiment 2, only with the highest doses (80 and 120 mg/kg bw). Blood samples were collected and the frequency of micronucleated polychromatic erythrocytes (MPCE), fMPCE and the cell proliferation, % PCE was determinated. All animals were observed during the experiment for side effects of the treatment. Based on the results from different analyses, the test substance has negative effect on tested animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.